id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-V-0146-0007,FDA,FDA-2007-V-0146,Acknowledgement Letter to Baylor University,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:33:53Z,,0,0,09000064807e13b2
FDA-1999-V-4083-0007,FDA,FDA-1999-V-4083,"FDA/CDRH Response to United Laser Artists, Inc. - Approval for Variance",Other,VRA-Approval for Variance,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T21:35:19Z,,0,0,09000064807e0d82
FDA-2008-P-0343-0013,FDA,FDA-2008-P-0343,Acknowledgement Letter to Novo Nordisk Inc.,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:34:25Z,,0,0,09000064807f8d4b
FDA-2008-P-0411-0009,FDA,FDA-2008-P-0411,Novo Nordisk Inc. - Petition for Stay of Action,Other,PSA-Petition for Stay,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-08-11T02:58:51Z,,0,0,09000064807f9170
FDA-2008-P-0411-0007,FDA,FDA-2008-P-0411,Novo Nordisk Inc. - Petition for Reconsideration,Other,PRC-Petition for Reconsideration,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2009-06-18T16:54:55Z,,0,0,09000064807f8de8
FDA-2008-P-0591-0003,FDA,FDA-2008-P-0591,"Regulus Pharmaceutical Consulting, Inc. - Amendment to Citizen Petition",Other,AMD-Amendment,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:34:24Z,,0,0,09000064807f25fd
FDA-2007-N-0475-0015,FDA,FDA-2007-N-0475,"Mylan Pharmaceuticals, Inc. (Mylan) - Letter",Other,LET-Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T20:26:19Z,,0,0,09000064808094ec
FDA-2008-P-0343-0011,FDA,FDA-2008-P-0343,Acknowledgement Letter to Novo Nordisk Inc.,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-08-11T04:30:35Z,,0,0,09000064807f915e
FDA-2008-P-0380-0004,FDA,FDA-2008-P-0380,FDA/CDER Interim Response to National Association of Chain Drug Stores - Letter,Other,LET-Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:34:49Z,,0,0,09000064808094f2
FDA-2008-P-0343-0012,FDA,FDA-2008-P-0343,Novo Nordisk Inc. - Petition for Stay of Action,Other,PSA-Petition for Stay,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-08-11T02:58:51Z,,0,0,09000064807f9130
FDA-1999-V-4083-0003,FDA,FDA-1999-V-4083,"FDA/CDRH Response to United Laser Artists, Inc. - Approval for Variance",Other,VRA-Approval for Variance,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T21:35:14Z,,0,0,09000064804f5ec4
FDA-1999-V-4083-0004,FDA,FDA-1999-V-4083,"United Laser Artists, Inc. Request for Extension of Compliance Date",Other,EXP-Request for Extension of Compliance Date,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T21:35:15Z,,0,0,09000064804f5ec5
FDA-2008-P-0660-0001,FDA,FDA-2008-P-0660,OncoTherapies Limited - Citizen Petition,Other,CP-Citizen Petition,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:34:18Z,,0,0,09000064807eedcc
FDA-2008-P-0660-0002,FDA,FDA-2008-P-0660,Acknowledgement Letter to OncoTherapies Limited,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-08-11T02:58:50Z,,0,0,09000064807ef0e8
FDA-2008-P-0662-0002,FDA,FDA-2008-P-0662,"Acknowledgement Letter to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-08-11T04:30:38Z,,0,0,09000064808080df
FDA-2007-P-0293-0004,FDA,FDA-2007-P-0293,Letter from David K. Richardson to FDA DMB,Other,Letter(s),2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2025-03-11T18:33:37Z,,0,0,09000064807df592
FDA-1999-V-4083-0005,FDA,FDA-1999-V-4083,"FDA/CDRH Response to United Laser Artists, Inc. - Approval for Variance",Other,VRA-Approval for Variance,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T21:35:16Z,,0,0,09000064804f5ec6
FDA-1999-V-4083-0002,FDA,FDA-1999-V-4083,"Acknowledgement Letter to United Laser Artists, Inc.",Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T21:35:13Z,,0,0,09000064804f5ec3
FDA-2008-P-0384-0004,FDA,FDA-2008-P-0384,FDA/CVM Interim Response to Laurie Rentas - Letter,Other,LET-Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T20:55:39Z,,0,0,09000064808094ee
FDA-2007-V-0146-0006,FDA,FDA-2007-V-0146,Baylor University - Request for Extension of Compliance Date,Other,VAR-Application for Variance,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T19:03:28Z,,0,0,09000064807e0b96
FDA-2007-N-0475-0009,FDA,FDA-2007-N-0475,"FDA/CDER/OGD - ""Response to Midodrine Application Holder""  - Letter",Other,LET-Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2010-08-31T15:00:44Z,,0,0,0900006480439408
FDA-2008-P-0411-0010,FDA,FDA-2008-P-0411,Acknowledgement Letter to Novo Nordisk Inc.,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-28T01:58:06Z,,0,0,09000064807f8e2e
FDA-2008-P-0411-0008,FDA,FDA-2008-P-0411,Acknowledgement Letter to Novo Nordisk Inc.,Other,ACK-Acknowledgement Letter,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:34:27Z,,0,0,09000064807f919e
FDA-1999-V-4083-0006,FDA,FDA-1999-V-4083,"United Laser Artists, Inc. Request for Extension of Compliance Date",Other,EXP-Request for Extension of Compliance Date,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T21:35:18Z,,0,0,0900006480785a13
FDA-2008-D-0053-0158,FDA,FDA-2008-D-0053,"Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices
Guidance for Industry",Other,Guidance,2008-12-31T05:00:00Z,2008,12,2020-05-13T04:00:00Z,,2024-11-06T23:36:21Z,,1,0,09000064845ef064
FDA-2008-P-0662-0001,FDA,FDA-2008-P-0662,"Lachman Consultant Services, Inc. - Citizen Petition",Other,CP-Citizen Petition,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2024-11-12T04:34:37Z,,1,0,09000064808080cb
FDA-2008-P-0343-0010,FDA,FDA-2008-P-0343,Novo Nordisk Inc. - Petition for Reconsideration,Other,PRC-Petition for Reconsideration,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2009-06-18T16:43:05Z,,0,0,09000064807f8ce8
FDA-1999-V-4083-0001,FDA,FDA-1999-V-4083,United Laser Artists Inc. - Request for Variance,Other,VAR-Application for Variance,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2008-12-31T21:35:11Z,,0,0,09000064804f5ec2
FDA-2008-P-0197-0004,FDA,FDA-2008-P-0197,"FDA Response to William J. Kennick, Esq. - Petition Denial",Other,PDN-Petition Denial,2008-12-31T05:00:00Z,2008,12,2008-12-31T05:00:00Z,,2013-07-27T22:34:19Z,,0,0,09000064807eef30
FDA-2008-P-0531-0129,FDA,FDA-2008-P-0531,"Richard F. Edlich, M.D., Ph.D. - (University of Virginia Health System) - Supplement Citizen Petition",Other,SUP-Supplement,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2010-04-28T03:55:03Z,,0,0,09000064807de339
FDA-2008-P-0605-0003,FDA,FDA-2008-P-0605,Woolsthorpe Technologies - Withdrawal of Petition for Reconsideration,Other,WDL-Withdrawal,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2008-12-30T22:03:15Z,,0,0,09000064807e388a
FDA-2008-P-0654-0001,FDA,FDA-2008-P-0654,Procter & Gamble Company - Citizen Petition,Other,CP-Citizen Petition,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2013-07-27T22:34:02Z,,0,0,09000064807e31cc
FDA-2008-P-0584-0002,FDA,FDA-2008-P-0584,"Acknowledgement Letter to Cohen, Tauber, Spievack & Wagner P.C.",Other,ACK-Acknowledgement Letter,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2008-12-30T16:35:33Z,,0,0,09000064807a92f0
FDA-1991-P-0058-0003,FDA,FDA-1991-P-0058,FDA/CFSAN Response to Lois M. Meyer - Letter,Other,LET-Letter,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2013-07-28T01:58:00Z,,0,0,09000064807e383a
FDA-2008-N-0523-0005,FDA,FDA-2008-N-0523,Plasma Protein Therapeutics Association (PPTA) - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2013-07-27T22:34:14Z,,0,0,09000064807e8734
FDA-2008-P-0654-0005,FDA,FDA-2008-P-0654,"Tab C - ""FDA Response Letter to Santarus, Inc. Dated June 10, 2004"" - [Proctor and Gamble - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-30T05:00:00Z,2008,12,,,2008-12-30T15:47:01Z,,0,0,09000064807e323b
FDA-2008-P-0358-0007,FDA,FDA-2008-P-0358,Interim Response Letter from FDA/CDER to James P. Reichmann,Other,Letter(s),2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2015-10-08T13:03:39Z,,0,0,09000064807e37ba
FDA-2008-P-0368-0007,FDA,FDA-2008-P-0368,FDA/CDER Interim Response to ISTA Pharmaceuticals - Letter,Other,LET-Letter,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2008-12-31T00:25:10Z,,0,0,0900006480807c1c
FDA-2008-N-0650-0001,FDA,FDA-2008-N-0650,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,N-Notice,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,2009-03-03T04:59:59Z,2024-11-12T04:27:47Z,E8-31058,1,0,09000064808079b5
FDA-1991-P-0058-0004,FDA,FDA-1991-P-0058,"Attachment 1 - ""Wonder Stoneground 100% Whole Wheat  Label"" - [Lois Meyer - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-30T05:00:00Z,2008,12,,,2008-12-31T00:00:52Z,,0,0,09000064807e31a3
FDA-1978-N-0018-0652,FDA,FDA-1978-N-0018,"Playtex Products, Inc. Comments to Proposed Monograph for OTC Sunscreen Products re: Comment from Energizer Personal Care (Playtex Products, Inc)",Supporting & Related Material,Background Material,2008-12-30T05:00:00Z,2008,12,,,2019-07-29T17:47:16Z,,0,0,090000648055c1e1
FDA-1991-P-0058-0001,FDA,FDA-1991-P-0058,Lois M. Meyer - Citizen Petition,Other,CP-Citizen Petition,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2013-07-28T01:42:43Z,,0,0,090000648052b9b2
FDA-2008-P-0584-0001,FDA,FDA-2008-P-0584,"Cohen, Tauber, Spievack & Wagner P.C - Citizen Petition",Other,CP-Citizen Petition,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2011-05-12T19:39:48Z,,0,0,09000064807a92d0
FDA-2008-P-0654-0002,FDA,FDA-2008-P-0654,Acknowledgement Letter to Procter & Gamble Company,Other,ACK-Acknowledgement Letter,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2008-12-30T15:46:18Z,,0,0,09000064807e32ef
FDA-2008-P-0654-0006,FDA,FDA-2008-P-0654,"Tab G - ""CDER OTC Medical Officer's Review"" - [Proctor & Gamble - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-30T05:00:00Z,2008,12,,,2008-12-30T15:47:02Z,,0,0,09000064807e32d7
FDA-2005-P-0381-0005,FDA,FDA-2005-P-0381,"Attachment 2 - Product Description for Diphenoxylate Hydrochloride and Atropin Sulfate Tablets and Oral Solution, 5 mg/0.05 mg re Citizens Petition from Lachman Consultant Services, Inc.",Supporting & Related Material,Background Material,2008-12-30T05:00:00Z,2008,12,,,2024-11-12T17:56:32Z,,0,0,09000064807ddd58
FDA-2007-N-0451-0005,FDA,FDA-2007-N-0451,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,N-Notice,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2008-12-30T13:05:40Z,E8-31057,0,0,09000064808079a6
FDA-2008-P-0654-0003,FDA,FDA-2008-P-0654,"Tab A - ""Clinical Review: Division of Gastrointestinal and Coagulation Drug Products"" - [Proctor & Gamble Company - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-30T05:00:00Z,2008,12,,,2008-12-30T15:49:04Z,,0,0,09000064807e31ff
FDA-2008-P-0654-0004,FDA,FDA-2008-P-0654,"Tab B - ""Memorandum - Director (Deputy) Summary Approval Comments NDA 21-636, Dated June 14, 2004"" - [Proctor & Gamble - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-30T05:00:00Z,2008,12,,,2008-12-30T15:48:20Z,,0,0,09000064807e3227
FDA-1991-P-0058-0002,FDA,FDA-1991-P-0058,Acknowledegement Letter to Lois M. Meyer,Other,ACK-Acknowledgement Letter,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2013-07-27T22:34:01Z,,0,0,09000064807e2f7c
FDA-1978-N-0018-0653,FDA,FDA-1978-N-0018,"Supplement from Energizer Personal Care (Playtex Products, Inc.)",Other,Supplement (SUP),2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2019-07-31T14:56:45Z,,0,0,09000064807df3d8
FDA-2006-P-0149-0004,FDA,FDA-2006-P-0149,Citizen Petition from Washington Legal Foundation (WLF),Other,Citizen Petition,2008-12-30T05:00:00Z,2008,12,2008-12-30T05:00:00Z,,2024-11-25T14:15:20Z,,1,0,09000064804504fa
FDA-2008-N-0039-0092,FDA,FDA-2008-N-0039,Freedom of Information Summary - Original Abbreviated New Drug Application - ANADA 200-459,Supporting & Related Material,Freedom of Information Summary,2008-12-29T05:00:00Z,2008,12,,,2013-07-09T18:51:04Z,,0,0,0900006480805f78
FDA-2008-N-0637-0001,FDA,FDA-2008-N-0637,Agency Information Collection Activities; Proposed Collection; Comment Request; Financial Disclosure by Clinical Investigators,Notice,N-Notice,2008-12-29T05:00:00Z,2008,12,2008-12-29T05:00:00Z,2009-02-28T04:59:59Z,2024-11-12T04:27:44Z,E8-30837,1,0,0900006480805ec3
FDA-2008-N-0652-0001,FDA,FDA-2008-N-0652,Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation,Notice,N-Notice,2008-12-29T05:00:00Z,2008,12,2008-12-29T05:00:00Z,2009-02-28T04:59:59Z,2024-11-12T04:27:11Z,E8-30839,1,0,0900006480805e3a
FDA-2008-N-0039-0091,FDA,FDA-2008-N-0039,Ophthalmic and Topical Dosage Form New Animal Drugs; Triamcinolone Cream,Rule,Final Rule,2008-12-29T05:00:00Z,2008,12,2008-12-29T05:00:00Z,,2013-07-09T18:48:19Z,E8-30694,0,0,0900006480805eeb
FDA-2008-P-0647-0003,FDA,FDA-2008-P-0647,"Attachment 1 - Clinoril® (Sulindac, 200mg Tablets) Product Description - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-24T05:00:00Z,2008,12,,,2008-12-24T15:06:35Z,,0,0,09000064807d93bb
FDA-2008-S-0350-0002,FDA,FDA-2008-S-0350,Public Submissions without Docket Number or ID,Other,SPE-No Docket ID,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2008-12-24T18:04:47Z,,0,0,09000064806279a5
FDA-2005-P-0134-0004,FDA,FDA-2005-P-0134,"Petition Denial from FDA CDER to Lachman Consultant Services, Inc.",Other,PDN-Petition Denial,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2024-11-12T18:26:40Z,,0,0,09000064807dcaef
FDA-2005-P-0134-0003,FDA,FDA-2005-P-0134,"Citizens Petition from Lachman Consultant Services, Inc.",Other,CP-Citizen Petition,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2024-11-12T18:24:31Z,,0,0,090000648043fe1e
FDA-2006-P-0007-0022,FDA,FDA-2006-P-0007,See Document ID FDA-2008-D-0626-0002 re Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl Notice of Availability  Reference,Supporting & Related Material,REF-Reference Material (external attachments),2008-12-24T05:00:00Z,2008,12,,,2014-02-01T00:56:34Z,,0,0,09000064807f2141
FDA-2005-P-0381-0004,FDA,FDA-2005-P-0381,"Petition Denial from FDA CDER to Lachman Consultant Services, Inc.",Other,PDN-Petition Denial,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2024-11-12T17:54:02Z,,0,0,09000064807dcb48
FDA-2005-P-0134-0005,FDA,FDA-2005-P-0134,"Attachment 1 - Approved Drug Products with Therapeutic Equivalence Evaluations (Electronic Orange Book), April 25, 2005 re Citizens Petition from Lachman Consultant Services, Inc.",Supporting & Related Material,Background Material,2008-12-24T05:00:00Z,2008,12,,,2024-11-12T18:30:08Z,,0,0,09000064807f8ef6
FDA-2008-P-0647-0004,FDA,FDA-2008-P-0647,"Attachment 2 - Product Description - Sulindac Capsules (Sulindac) - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-24T05:00:00Z,2008,12,,,2008-12-24T15:06:37Z,,0,0,09000064807d93dc
FDA-2008-P-0647-0005,FDA,FDA-2008-P-0647,"Attachment 3 - Approved Drug Products with Therapeutic Equivalence Evaluations, 28th Edition - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-24T05:00:00Z,2008,12,,,2008-12-24T15:06:38Z,,0,0,09000064807d9426
FDA-2008-S-0350-0001,FDA,FDA-2008-S-0350,Food Additives Permitted in Feed and Drinking Water of Animals,Rule,NCR-Notice of Correction,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2008-12-24T17:44:31Z,E8-30840,0,0,09000064807f8dc4
FDA-2008-N-0045-0008,FDA,FDA-2008-N-0045,"Regulatory Site Visit Training Program; December 24, 2008",Notice,N-Notice,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,2009-01-24T04:59:59Z,2010-03-26T22:43:43Z,E8-30659,0,0,09000064807f8e05
FDA-2005-P-0381-0003,FDA,FDA-2005-P-0381,"Citizens Petition from Lachman Consultant Services, Inc.",Other,CP-Citizen Petition,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2024-11-12T17:52:49Z,,0,0,090000648044bec6
FDA-1994-N-0182-0048,FDA,FDA-1994-N-0182,Transcript of the Pubic Hearing on Acyclovir - Transcript,Other,TR-Transcript,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:45Z,,0,0,090000648070b75e
FDA-1994-N-0182-0009,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:01Z,,0,0,090000648050714a
FDA-1994-N-0182-0027,FDA,FDA-1994-N-0182,Harvard Medical School - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:21Z,,0,0,0900006480507164
FDA-1994-N-0182-0022,FDA,FDA-1994-N-0182,Association of Reproductive Professional - Supplement,Other,SUP-Supplement,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:15Z,,0,0,090000648050715e
FDA-1994-N-0182-0005,FDA,FDA-1994-N-0182,Distribution of FR Notice for Acyclovir Public Hearing - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:57Z,,0,0,0900006480507146
FDA-1994-N-0182-0040,FDA,FDA-1994-N-0182,American Social Health Association - Testimony,Other,TS-Testimony,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-08-11T02:40:17Z,,0,0,0900006480507187
FDA-1978-N-0018-0644,FDA,FDA-1978-N-0018,Citizen Petition from The International Center for Technology Assessment,Other,Citizen Petition,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2019-07-31T18:01:58Z,,0,0,090000648055a922
FDA-1978-N-0018-0648,FDA,FDA-1978-N-0018,Acknowledgment Letter from FDA to Ciba Corporation,Other,Acknowledgement Letter/Receipt,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2019-07-30T16:41:18Z,,0,0,09000064807d5c45
FDA-1978-N-0018-0646,FDA,FDA-1978-N-0018,Citizen Petition from Ciba Corporation,Other,Citizen Petition,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2019-08-02T01:01:01Z,,0,0,09000064807d5b6c
FDA-1994-N-0182-0003,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:54Z,,0,0,0900006480507144
FDA-1994-N-0182-0046,FDA,FDA-1994-N-0182,HFD-9 - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:43Z,,0,0,09000064805071be
FDA-1994-N-0182-0013,FDA,FDA-1994-N-0182,"Denise M. Buntin, M.D. - Appearance Request",Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-08-11T02:40:16Z,,0,0,0900006480507150
FDA-1994-N-0182-0020,FDA,FDA-1994-N-0182,American Academy of Dermatology - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,090000648050715a
FDA-1994-N-0182-0031,FDA,FDA-1994-N-0182,Nonprescription Drug Manufacturers Assn. - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:26Z,,0,0,090000648050716f
FDA-1994-N-0182-0030,FDA,FDA-1994-N-0182,Center for Disease Control and Prevention - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:25Z,,0,0,090000648050716e
FDA-2004-D-0375-0019,FDA,FDA-2004-D-0375,Guidance for Industry and Food and Drug Administration Staff; ``Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300; Availability,Notice,NAD-Notice of Availability of Data,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T12:40:16Z,E8-30586,0,0,09000064807eda05
FDA-2008-N-0644-0001,FDA,FDA-2008-N-0644,SEQC--The Sequencing Quality Control Project,Notice,N-Notice,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T12:54:12Z,E8-30410,0,0,09000064807eda32
FDA-1994-N-0182-0049,FDA,FDA-1994-N-0182,Index - List,Other,LST-List,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:47Z,,0,0,090000648070b89e
FDA-1978-N-0018-0645,FDA,FDA-1978-N-0018,Citizen Petition from Schering-Plough Corporation,Other,Citizen Petition,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2019-07-30T16:47:54Z,,0,0,090000648055aa39
FDA-1994-N-0182-0018,FDA,FDA-1994-N-0182,National Women's Health Network - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507156
FDA-1994-N-0182-0026,FDA,FDA-1994-N-0182,Infectious Diseases Society of America - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:20Z,,0,0,0900006480507163
FDA-1994-N-0182-0007,FDA,FDA-1994-N-0182,Distribution of FR Notice for Acyclovir Public Hearing - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:59Z,,0,0,0900006480507148
FDA-1994-N-0182-0006,FDA,FDA-1994-N-0182,"FDA ""Dear Colleague"" Letter",Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:00:58Z,,0,0,0900006480507147
FDA-1994-N-0182-0044,FDA,FDA-1994-N-0182,Harvard Medical School - Letter,Other,LET-Letter,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:41Z,,0,0,09000064805071aa
FDA-1994-N-0182-0019,FDA,FDA-1994-N-0182,University of Kansas Medical Center - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507157
FDA-1994-N-0182-0015,FDA,FDA-1994-N-0182,The Center for Proper Medication Use - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507152
FDA-1994-N-0182-0042,FDA,FDA-1994-N-0182,HFD-336 - Memorandum,Other,M-Memorandum,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:39Z,,0,0,0900006480507198
FDA-1994-N-0182-0017,FDA,FDA-1994-N-0182,University of Pittsburgh - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507154
FDA-1994-N-0182-0032,FDA,FDA-1994-N-0182,"Denise M. Buntin, M.D., P.C - Wthdrawal",Other,WDL-Withdrawal,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,0900006480507171
FDA-1994-N-0182-0021,FDA,FDA-1994-N-0182,Infectious Diseases Society for Ob-Gyn - Appearance Request,Other,APE-Appearance Request,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2013-07-27T21:20:30Z,,0,0,090000648050715b
FDA-1994-N-0182-0033,FDA,FDA-1994-N-0182,HFD-9 - List,Other,LST-List,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T21:01:29Z,,0,0,0900006480507173
FDA-2008-N-0648-0001,FDA,FDA-2008-N-0648,Agency Information Collection Activities; Proposed Collection; Comment Request; PDUFA Pilot Project Proprietary Name Review,Notice,N-Notice,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,2009-02-24T04:59:59Z,2008-12-23T12:59:23Z,E8-30587,0,0,09000064807eda6f